IKC is working to improve vaccination rates in the state of Kansas, paying special attention to adolescent vaccines. There are two types of meningococcal vaccines licensed in the United States: Meningococcal conjugate vaccines (MenACWY) and Serogroup B meningococcal vaccine (MenB). These vaccines help prevent the most common causes of meningococcal disease in the U.S.
Originally, IKC's goal with this toolkit was to increase MenACWY vaccination rates to meet the Healthy People 2020 goal of 80%. Since 2019, the rate of Kansas teens receiving at least one dose of the quadrivalent meningococcal conjugate vaccine has met or exceeded the 80% goal, but Kansas still has one of the lowest vaccination rates in the country.
These resources are designed for health care professionals for education and administration of meningococcal vaccinations.
These resources are designed for parents, families, and adolescents on the importance of getting a meningococcal vaccination.
Bundling Language is when a provider recommends multiple vaccines to be administered at the same time.
© 2015 -
Immunize Kansas Coalition is an independent 501(c)(3) non profit organization.| © 2015 -
Immunize Kansas Coalition is an independent 501(c)(3) non profit organization.
Supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $79,278,482 with 100% funded by the CDC/HHS.
The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, the CDC/HHS, the U.S. Government, or the Office of the Kansas Governor. For more information, please visit https://www.cdc.gov. [revision 10/01/21].